about
Recent Advances in CRISPR-Cas9 Genome Editing Technology for Biological and Biomedical Investigations.CRISPR-barcoding in non small cell lung cancer: from intratumor genetic heterogeneity modeling to cancer therapy application.Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications.Animal models of cholangiocarcinoma.Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
CRISPR-Cas9: from Genome Editing to Cancer Research
@ast
CRISPR-Cas9: from Genome Editing to Cancer Research
@en
CRISPR-Cas9: from Genome Editing to Cancer Research
@nl
type
label
CRISPR-Cas9: from Genome Editing to Cancer Research
@ast
CRISPR-Cas9: from Genome Editing to Cancer Research
@en
CRISPR-Cas9: from Genome Editing to Cancer Research
@nl
prefLabel
CRISPR-Cas9: from Genome Editing to Cancer Research
@ast
CRISPR-Cas9: from Genome Editing to Cancer Research
@en
CRISPR-Cas9: from Genome Editing to Cancer Research
@nl
P2093
P2860
P921
P356
P1476
CRISPR-Cas9: from Genome Editing to Cancer Research
@en
P2093
P2860
P304
P356
10.7150/IJBS.17421
P407
P577
2016-11-04T00:00:00Z